Li, Yijing
Lee, Heng-Huan
Jiang, Vivian Changying
Che, Yuxuan
McIntosh, Joseph
Jordan, Alexa
Vargas, Jovanny
Zhang, Tianci
Yan, Fangfang http://orcid.org/0000-0001-6231-5225
Simmons, Margaret Elizabeth
Wang, Wei
Nie, Lei
Yao, Yixin http://orcid.org/0000-0002-8439-6043
Jain, Preetesh
Wang, Michael http://orcid.org/0000-0001-9748-5486
Liu, Yang http://orcid.org/0000-0002-1910-8076
Funding for this research was provided by:
This study was supported by an SRA grant from AstraZeneca and philanthropic funds from the Kimmel Research fund and various donor funds
Article History
Received: 16 June 2023
Revised: 11 October 2023
Accepted: 18 October 2023
First Online: 2 November 2023
Competing interests
: MW is consultant to AbbVie, Acerta Pharma, AstraZeneca, BeiGene, BioInvent, Deciphera, InnoCare, Janssen, Kite Pharma, Leukemia & Lymphoma Society, Lilly, Merck, Milken Institute, Oncternal, Parexel, Pepromene Bio, Pharmacyclics, and VelosBio, and he has received research support from Acerta Pharma, AstraZeneca, BeiGene, BioInvent, Celgene, Genmab, Genentech, Innocare, Janssen, Juno Therapeutics, Kite Pharma, Lilly, Loxo Oncology, Molecular Templates, Oncternal, Pharmacyclics, VelosBio, Vincerx. M.W. also received a speaker honorarium from AbbVie, Acerta Pharma, AstraZeneca, BeiGene, BioInvent, Dava Oncology, Eastern Virginia Medical School, IDEOlogy Health, Janssen, Kite Pharma, Leukemia & Lymphoma Society, LLC TS Oncology, Medscape, Meeting Minds Experts, MJH Life Sciences, Merck, Moffit Cancer Center, Oncology Specialty Group, OncLive, Pharmacyclics, Physicians Education Resources (PER), Practice Point Communications (PPC), and Studio ER Congressi. The remaining authors declare no competing interests.
: Cell samples were acquired from patients and healthy donors after obtaining written informed consent following the University of Texas MD Anderson Cancer Center Institutional Review Board-approved protocols and in accordance with the Declaration of Helsinki. The Institutional Animal Care and Use Committee of The University of Texas MD Anderson Cancer Center approved the experimental protocols involving animals.
: All the authors have read and approved the manuscript for publication.